Drug companies pay out millions after overcharging Medicaid

States, safety net providers recover millions from Medicaid fraud schemes.

After All, Only Millions?

An update on the census of species of Archaea and Bacteria published recently in mBio (P. D. Schloss, R. A. Girard, T. Martin, J. Edwards, and J. C. Thrash, mBio 7:e00201-16, 2016, http://dx.doi.org/10.1128/mBio.00201-16) showed again that, despite ever-increasing sequencing efforts, the PCR-based retrieval of 16S rRNA genes is approaching saturation. On average, 95% of the genes analyzed today...

Doctors and Drug Companies: Still Cozy after All These Years

Geoff Spurling and colleagues report findings of a systematic review looking at the relationship between exposure to promotional material from pharmaceutical companies and the quality, quantity, and cost of prescribing. They fail to find evidence of improvements in prescribing after exposure, and find some evidence of an association with higher prescribing frequency, higher costs, or lower pres...

Doctors and drug companies.

When a great profession and the forces of capitalism interact, drama is likely to result. This has certainly been the case where the profession of medicine and the pharmaceutical industry are concerned. On display in the relationship between doctors and drug companies are the grandeur and weaknesses of the medical profession — its noble aspirations and its continuing inability to fulfill them. ...

Do Companies Pay CIOs More After the Adoption of International Financial Accounting Standards?

This study investigates the association between regulatory reporting change and Chief Information Officer (CIO) pay. Mandatory reporting standards change such as International Financial Reporting Standards (IFRS) calls for the increased information systems demand in order to provide satisfactory reporting quality. Anecdote evidence suggests that CIOs, who are responsible for managing informatio...